Deferred Tax Assets, Valuation Allowance of IMMUNIC, INC. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IMMUNIC, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • IMMUNIC, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $119,873,000, a 2.4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

IMMUNIC, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $119,873,000 +$2,795,000 +2.4% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $117,078,000 +$18,027,000 +18% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $99,051,000 +$25,998,000 +36% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $73,053,000 +$14,236,000 +24% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $58,817,000 +$22,300,000 +61% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 $36,517,000 +$8,162,000 +29% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $28,355,000 +$22,335,000 +371% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $6,020,000 -$77,832,000 -93% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q4 2017 $83,852,000 +$14,242,000 +20% 31 Dec 2017 10-K 04 Mar 2019 2018 FY
Q4 2016 $69,610,000 +$7,333,000 +12% 31 Dec 2016 10-K 13 Mar 2018 2017 FY
Q4 2015 $62,277,000 +$22,520,000 +57% 31 Dec 2015 10-K 07 Mar 2017 2016 FY
Q4 2014 $39,757,000 +$21,507,000 +118% 31 Dec 2014 10-K 08 Mar 2016 2015 FY
Q4 2013 $18,250,000 31 Dec 2013 10-K 20 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.